Amgen
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Amgen (AMGN) SEC Filings
Browse all Amgen SEC filings, including Annual reports (10-K), Quarterly reports (10-Q), 8-K, proxy statements (DEF 14A), and insider filings (Form 4). Access official documents by filing date, reporting period, and form type. ...more
Amgen Reports: Annual 10-K, Quarterly 10-Q & SEC Filings
SEC Filings
Date
2026
DEFA14A
Additional or supplemental proxy disclosures
DEF 14A
Final shareholder voting details (board elections and executive pay)
ARS
Annual Report to Shareholders
SC 13G/A
Updated passive ownership disclosure
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
25-NSE
Exchange-filed notice of delisting
4
Insider ownership (buying, selling) activity
424B2
Prospectus variant for specific offering structures
8-K
Material company events (earnings, M&A, or leadership changes)
424B3
Updated prospectus reflecting new or changed information
FWP
Free writing prospectus related to a securities offering
10-K
Annual financial results and management updates
S-3ASR
Automatic shelf registration for eligible issuers
4
Insider ownership (buying, selling) activity
8-K
Material company events (earnings, M&A, or leadership changes)
8-K
Material company events (earnings, M&A, or leadership changes)
2025
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
Amgen (Form DEFA14A) 2026
Proxy & Voting / Additional or supplemental proxy disclosures
Apr 7, 2026
